Litigation Details for Silvergate Pharmaceuticals, Inc. v. Bionpharma Inc. (D. Del. 2020)

Silvergate Pharmaceuticals, Inc. v. Bionpharma Inc. (D. Del. 2020)

Docket		Date Filed	2020-09-18
Court	District Court, D. Delaware	Date Terminated
Cause		Assigned To	Leonard Philip Stark
Jury Demand		Referred To
Parties	BIONPHARMA INC.
Patents	10,039,745; 10,154,987; 6,869,939; 8,008,006; 8,236,782; 8,343,995; 8,568,747; 8,835,407; 8,853,236; 9,000,011; 9,669,008; 9,808,442
Attorneys	Richard T. Ruzich
Firms	Morris James LLP
Link to Docket	External link to docket

Biologic Drugs cited in Silvergate Pharmaceuticals, Inc. v. Bionpharma Inc.

Details for Silvergate Pharmaceuticals, Inc. v. Bionpharma Inc. (D. Del. 2020)

Date Filed	Document No.	Description	Snippet	Link To Document
2020-10-26	16	Redacted Document	the ’745 Patent U.S. Patent No. 10,039,745 the ’987 Patent U.S. Patent No. 10,154,987 Original…regarding U.S. Patent Nos. 9,669,008 (the “’008 Patent”); 9,808,442 (the “’442 Patent”); 10,039,745 (the “’745…Application the ’008 Patent U.S. Patent No. 9,669,008 the ’442 Patent U.S. Patent No. 9,808,442 the…the ’868 patent U.S. Patent No. 10,772,868 New Patents The ’482 and ’868 patents, collectively… ’745 Patent / ’987 Patent ’868 Patent ’482 Patent Limitation	External link to document
2021-04-05	74	Exhibits A-C	.S. Patent No. 9,669,008, U.S. Patent No. 9,808,442, U.S. Patent No. 10,039,745, and U.S. Patent No.….S. Patent No. 9,669,008, U.S. Patent No. 9,808,442, U.S. Patent No. 10,039,745, and U.S. Patent No.….S. Patent No. 9,669,008, U.S. Patent No. 9,808,442, U.S. PatentNo. 10,039,745, and U.S. PatentNo. 10,154,987…U.S. Patent Application No. 15/802,341, filed November 2, 2017 (now U.S. Patent No. 10,039,745, issued…nonstatutory double patenting as being unpatentable over claims 1-20 of U.S. Patent No. 10,039,745, herein referred	External link to document